Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples.

Gamboa, F; Cardona, P J; Manterola, J M; Lonca, J; Matas, L; Padilla, E; Manzano, J R; Ausina, V

Gamboa, F; Cardona, P J; Manterola, J M; Lonca, J; Matas, L; Padilla, E; Manzano, J R; Ausina, V.

Affiliation

Gamboa F; Servicio de Microbiología, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain.

Eur J Clin Microbiol Infect Dis ; 17(3): 189-92, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9665301

Subject(s)

Antibiotics, Antitubercular/therapeutic use; Mycobacterium tuberculosis/drug effects; Rifampin/therapeutic use; Sputum/microbiology; Tuberculosis, Pulmonary/drug therapy; Drug Resistance, Microbial; Humans; Tuberculosis, Pulmonary/microbiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Sputum / Tuberculosis, Pulmonary / Antibiotics, Antitubercular / Mycobacterium tuberculosis Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Eur J Clin Microbiol Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 1998 Document type: Article Affiliation country: Spain Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links